SC 13G

SABBY 13G TNXP 12.19.18

Company: Tonix Pharmaceuticals Holding Corp.
Filed: December 19, 2018
Accession Number: 0001535610-18-000106

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →

View Document ↗ View on SEC.gov ↗